Talk:Cortical thymic epithelial cells
![]() | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||
|
Cathepsin L
editThis article refers to cathepsin L, but it didn't specify whether it's L1 or L2. The sources cited in the article and their transitive sources used the abbreviations CTSL and CatL, which are only supposed to be used for L1, but I wanted to make sure before I link to it, so I did some detective work. The sources and their transitive sources (specifically the ones used to cite cathepsin L-related claims) all refer to cathepsin L as if there's no possibility of confusion, so presumably they're all referring to the same one. Given that the paper describing the discovery of L2 was only published in April 1998 and received by the journal in November 1997,[1] everything published much earlier than that must refer to L1, and that includes many of the sources of this source[2] which is used in this source[3] which is used in this article.
Therefore, both this source[3] and the other one (which is cited by it and has a shared author) can be assumed to refer to L1. Hopefully. Streded (talk) 02:58, 1 February 2022 (UTC)
References
- ^ "Cathepsin L2, a Novel Human Cysteine Proteinase Produced by Breast and Colorectal Carcinomas". Cancer Research. PMID 9563472.
- ^ "The p41 isoform of invariant chain is a chaperone for cathepsin L". EMBO J. PMID 11483509.
- ^ a b Honey, Karen; Nakagawa, Terry; Peters, Christoph; Rudensky, Alexander (2002-05-20). "Cathepsin L Regulates CD4+ T Cell Selection Independently of Its Effect on Invariant Chain". The Journal of Experimental Medicine. 195 (10): 1349–1358. doi:10.1084/jem.20011904. ISSN 0022-1007. PMC 2193748. PMID 12021314.